Nasal-type NK/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behavior

被引:38
作者
Hong, Mineui [1 ,2 ]
Lee, Taehee [1 ]
Kang, So Young [1 ]
Kim, Suk-Jin [3 ]
Kim, Wonseog [3 ]
Ko, Young-Hyeh [1 ]
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pathol, Seoul 06351, South Korea
[2] Hallym Univ, Kangnam Sacred Heart Hosp, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Sect Hematol Oncol,Internal Med, Seoul, South Korea
关键词
MURINE BONE-MARROW; POLYMERASE-CHAIN-REACTION; NATURAL-KILLER-CELL; CONCURRENT CHEMORADIOTHERAPY; CLONAL IMMUNOGLOBULIN; EXPRESSION; LYMPHOPROLIFERATIONS; TRANSCRIPTION; PROTOCOLS; STRATEGY;
D O I
10.1038/modpathol.2016.47
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Extranodal natural killer (NK)/T-cell lymphoma (ENKTL), nasal type, comprises NK or cytotoxic T cells. We evaluated the clinical impact of cell type and the usefulness of T-cell receptor (TCR) gene transcripts in distinguishing cell lineage. One hundred and eight cases of ENKTL were analyzed for TCR gene rearrangements using the BIOMED-2 protocol and for TCR gene expression using immunohistochemistry for TCR-beta F1 and TCR-c gamma M1, and RNA in situ hybridization for TCR gene transcripts. Prognostic factors were analyzed. Among the 108 cases, 44 were monoclonal for a TCR rearrangement (40%) while 64 (60%) were undefinable. The monoclonal cases expressed TCR-beta F1 in 14 out of 40 cases (35%) and TCR-c gamma M1 in 1 out of 44 cases (2%). The 64 undetermined cases expressed TCR-beta F1 in 15 cases (23%) and TCR-c gamma M1 in 1 (2%). Thirteen of 40 TCR-beta constant gene transcript-positive cases (33%) expressed TCR-beta F1 and one of nine TCR-gamma constant gene transcript-positive cases (11%) expressed TCR-c gamma M1. TCR gene transcripts were not useful in the distinction of cell lineages. TCR gene transcripts were positive in ENKTLs as well as in normal B cells and aggressive NK-cell leukemia. Based on gene rearrangements and immunohistochemistry for TCR, there were 60 T-cell type cases (56%), 32 NK-cell type cases (30%), and 16 cases with an undetermined cell type (14%). TCR protein was expressed in 30/60 T-ENKTLs (50%) in a variable fraction of tumor cells. There were no significant differences in clinical findings or overall patient survival between T-or NK-cell types of ENKTL, although those with a T-cell type tended to show a better prognosis for those with localized nasal lymphomas. Univariate and multivariate analysis showed that a non-nasal ENKTL, age 460 years, high level of lactate dehydrogenase, bone marrow involvement, and the absence of radiotherapy were independent prognostic factors.
引用
收藏
页码:430 / 443
页数:14
相关论文
共 45 条
[1]   Expression of T-cell receptor genes during early T-cell development [J].
Abbey, Janice L. ;
O'Neill, Helen C. .
IMMUNOLOGY AND CELL BIOLOGY, 2008, 86 (02) :166-174
[2]   Expression of TCR-V peptides by murine bone marrow cells does not identify T-cell progenitors [J].
Abbey, Janice L. ;
Karsunky, Holger ;
Serwold, Thomas ;
Papathanasiou, Peter ;
Weissman, Irving L. ;
O'Neill, Helen C. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (08) :1956-1964
[3]  
[Anonymous], 2008, WHO CLASSIFICATION T
[4]   Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project [J].
Au, Wing-yan ;
Weisenburger, Dennis D. ;
Intragumtornchai, Tanin ;
Nakamura, Shigeo ;
Kim, Won-Seog ;
Sng, Ivy ;
Vose, Julie ;
Armitage, James O. ;
Liang, Raymond .
BLOOD, 2009, 113 (17) :3931-3937
[5]   Extranodal NK/T-cell lymphoma, nasal type: Study of clinicopathologic and prognosis factors in a series of 78 cases from Peru [J].
Barrionuevo, Carlos ;
Zaharia, Mayer ;
Martinez, Marco T. ;
Taxa, Luis ;
Misad, Oscar ;
Moscol, Alfredo ;
Sarria, Gustavo ;
Guerrero, Ivonne ;
Casanova, Luis ;
Flores, Claudio ;
Zevallos-Giampietri, Eduardo-Alfredo .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2007, 15 (01) :38-44
[6]   Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936 [J].
Brueggemann, M. ;
White, H. ;
Gaulard, P. ;
Garcia-Sanz, R. ;
Gameiro, P. ;
Oeschger, S. ;
Jasani, B. ;
Ott, M. ;
Delsol, G. ;
Orfao, A. ;
Tiemann, M. ;
Herbst, H. ;
Langerak, A. W. ;
Spaargaren, M. ;
Moreau, E. ;
Groenen, P. J. T. A. ;
Sambade, C. ;
Foroni, L. ;
Carter, G. I. ;
Hummel, M. ;
Bastard, C. ;
Davi, F. ;
Delfau-Larue, M. -H. ;
Kneba, M. ;
van Dongen, J. J. M. ;
Beldjord, K. ;
Molina, T. J. .
LEUKEMIA, 2007, 21 (02) :215-221
[7]  
Chan JKC., 2008, World health organization classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues, P285
[8]   BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan [J].
Chen, Yi-Lin ;
Su, Ih-Jen ;
Cheng, Hsieh-Yin ;
Chang, Kung-Chao ;
Lu, Cheng-Chan ;
Chow, Nan-Haw ;
Ho, Chung-Liang ;
Huang, Wenya .
LEUKEMIA & LYMPHOMA, 2010, 51 (04) :650-655
[9]  
Cheuk W, 2011, HEMATOPATHOLOGY, P473
[10]   NK-cell Lineage Predicts Poor Survival in Primary Intestinal NK-cell and T-cell Lymphomas [J].
Chuang, Shih-Sung ;
Chang, Sheng-Tsung ;
Chuang, Wen-Yu ;
Huang, Wan-Ting ;
Hsieh, Pin-Pen ;
Tsou, Mei-Hua ;
Liao, Yung-Liang ;
Lin, Shu-Hui ;
Hsieh, Yen-Chuan ;
Lu, Chin-Li ;
Sheu, Ming-Jen ;
Liu, Hongxiang .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (08) :1230-1240